Showing results (811-820 of 1,211) with videos related to
Sort By:
Pageof 122
European Journal of Heart Failure|April 13, 2025
Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialJawad H Butt, Pardeep S Jhund, Alasdair D Henderson, et al.European Journal of Heart Failure|May 16, 2025
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialJonathan W Cunningham, Brian L Claggett, Muthiah Vaduganathan, et al.Pilot and Feasibility Studies|April 22, 2022
Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 TrialNiklas Dyrby Johansen, Daniel Modin, Joshua Nealon, et al.Journal of the American Heart Association|February 23, 2024
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF TrialsAnkeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett, et al.European Journal of Heart Failure|September 29, 2023
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fractionShingo Matsumoto, Toru Kondo, Mingming Yang, et al.Journal of the American College of Cardiology|August 27, 2025
Adiposity-Related Anthropometrics and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Participant-Level Pooled Analysis of Randomized Clinical TrialsJohn W Ostrominski, Mats C Højbjerg Lassen, Jawad H Butt, et al.The American Journal of Cardiology|October 27, 2019
Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial)Thomas C Hanff, David M Kaye, Christopher S Hayward, et al.Journal of the American College of Cardiology|September 2, 2025
Natriuretic Peptides, Body Mass Index, and Clinical Outcomes in Heart Failure with Mildly Reduced or Preserved Ejection FractionJohn W Ostrominski, Brendon L Neuen, Brian L Claggett, et al.JAMA Cardiology|August 7, 2024
Rates of Sudden Death After Myocardial Infarction-Insights From the VALIANT and PARADISE-MI TrialsJames P Curtain, Marc A Pfeffer, Eugene Braunwald, et al.Journal of the American College of Cardiology|February 2, 2018
Improving Heart Failure Therapeutics Development in the United States: The Heart Failure CollaboratoryChristopher M O'Connor, Mitchell A Psotka, Mona Fiuzat, et al.Pageof 122